The TRPC5 receptor as pharmacological target for pain and metabolic disease.

MLA

Khare, Pragyanshu, et al. “The TRPC5 Receptor as Pharmacological Target for Pain and Metabolic Disease.” Pharmacology & Therapeutics, vol. 263, Nov. 2024, p. 108727. EBSCOhost, https://doi.org/10.1016/j.pharmthera.2024.108727.

APA

Khare, P., Chand, J., Ptakova, A., Liguori, R., Ferrazzi, F., Bishnoi, M., Vlachova, V., & Zimmermann, K. (2024). The TRPC5 receptor as pharmacological target for pain and metabolic disease. Pharmacology & Therapeutics, 263, 108727. https://doi.org/10.1016/j.pharmthera.2024.108727

Chicago

Khare, Pragyanshu, Jagdish Chand, Alexandra Ptakova, Renato Liguori, Fulvia Ferrazzi, Mahendra Bishnoi, Viktorie Vlachova, and Katharina Zimmermann. 2024. “The TRPC5 Receptor as Pharmacological Target for Pain and Metabolic Disease.” Pharmacology & Therapeutics 263 (November): 108727. doi:10.1016/j.pharmthera.2024.108727.